Ryan J. Taft, PhD is Chief Scientific Officer at Genetic Alliance, and Head, Precision Medicine at EspeRare, where he leads global programs focused on expanding access to advanced genomic diagnostics and therapies for individuals with rare and undiagnosed diseases. He is the scientific founder and strategic lead of the iHope program, a distributed international network delivering clinical genome sequencing to underserved patients worldwide. He also leads a global consortium dedicated to bringing tailored antisense oligonucleotide therapies to children outside the United States. Previously, Dr. Taft held senior leadership roles at Illumina and Tempus AI, where he helped shape large-scale genomics platforms spanning technology development, clinical translation, and data-driven precision medicine. Across industry and nonprofit settings, his work has centered on integrating cutting-edge technologies with real-world clinical workflows to improve patient outcomes. Dr. Taft holds a PhD in genomics and computational biology and has authored numerous publications in human genetics and genome biology.